Axa Equitable Holdings Inc (EQH) Peer Comparison
$53.26
As on 12-Oct-2026 13:42EDT
Market cap
$14,435 Mln
Revenue (TTM)
$10,615 Mln
P/E Ratio
--
P/B Ratio
164.1
Div. Yield
2.1 %
| Axa Equitable Holdings Inc (EQH) | CME Group Inc. Class A (CME) | Intercontinental Exchange (ICE) | Nasdaq (NDAQ) | Cboe Global Markets (CBOE) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
14,435 | 100,884 | 87,213 | 52,348 | 31,764 |
Revenue ($ Mln) |
10,615 | 6,773 | 12,479 | 8,707 | 5,061 |
Net Profit ($ Mln) |
-926.00 | 4,272.10 | 4,027.00 | 1,968.00 | 1,353.10 |
Net Margin (%) |
-8.72 | 63.08 | 32.27 | 22.60 | 26.73 |
RoE (%) |
-- | 15.47 | 13.56 | 16.25 | 25.14 |
Price to Earnings |
-- | 23.44 | 21.52 | 27.30 | 23.71 |
Price-To-Book |
164.14 | 3.67 | 2.97 | 4.45 | 4.99 |
Income Statement ($ Mln)
| Axa Equitable Holdings Inc (EQH) | CME Group Inc. Class A (CME) | Intercontinental Exchange (ICE) | Nasdaq (NDAQ) | Cboe Global Markets (CBOE) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
10,615.00 | 6,772.60 | 12,479.00 | 8,707.00 | 5,061.30 |
|
Cost of Revenue
|
2,901.00 | 1,226.40 | 3,568.00 | 3,539.00 | 2,414.50 |
|
Gross Profit
|
9,232.00 | 5,613.60 | 7,821.00 | 3,939.00 | 2,306.70 |
|
Operating Expenses
|
8,324.00 | 1,137.20 | 4,422.00 | 2,418.00 | 866.10 |
|
Operating Profit (EBIT)
|
-610.00 | 4,409.00 | 5,434.00 | 2,750.00 | 1,780.70 |
|
Other Income
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
-610.00 | 5,594.00 | 5,335.00 | 2,439.00 | 1,892.00 |
|
Provision for Tax
|
-84.00 | 1,321.90 | 1,246.00 | 471.00 | 538.90 |
|
Profit after Tax (Net Income)
|
-926.00 | 4,272.10 | 4,027.00 | 1,968.00 | 1,353.10 |
|
Minority Interest
|
-400.00 | 0.00 | -62.00 | 0.00 | 0.00 |
|
Consolidated Profit
|
-1,123.00 | 0.00 | 1,667.00 | 0.00 | 0.00 |
Liabilities ($ Mln)
| Axa Equitable Holdings Inc (EQH) | CME Group Inc. Class A (CME) | Intercontinental Exchange (ICE) | Nasdaq (NDAQ) | Cboe Global Markets (CBOE) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
-785.00 | 26,520.40 | 29,551.00 | 11,988.00 | 5,625.80 |
|
Minority Interest
|
-400.00 | 0.00 | -62.00 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
329,430.00 | 9,438.90 | 24,019.00 | 11,774.00 | 1,197.00 |
|
Current Liabilities
|
4,004.00 | 158,785.30 | 120,576.00 | 3,574.00 | 3,786.50 |
|
Total Liabilities
|
317,990.00 | 198,548.40 | 136,887.00 | 31,053.00 | 9,305.30 |
Assets ($ Mln)
| Axa Equitable Holdings Inc (EQH) | CME Group Inc. Class A (CME) | Intercontinental Exchange (ICE) | Nasdaq (NDAQ) | Cboe Global Markets (CBOE) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
294,210.00 | 33,045.50 | 52,183.00 | 25,613.00 | 4,682.50 |
|
Current Assets
|
40,447.00 | 161,631.10 | 122,064.00 | 1,728.00 | 5,926.80 |
|
Total Assets
|
317,990.00 | 198,548.40 | 136,887.00 | 31,053.00 | 9,305.30 |
|
Total Debt*
|
3,839.00 | 3,424.20 | 20,527.00 | 9,243.00 | 1,555.30 |
|
Net Current Assets
|
0.00 | 2,913.80 | 1,488.00 | 28.00 | 2,140.30 |
Cashflow ($ Mln)
| Axa Equitable Holdings Inc (EQH) | CME Group Inc. Class A (CME) | Intercontinental Exchange (ICE) | Nasdaq (NDAQ) | Cboe Global Markets (CBOE) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
713.00 | 4,277.10 | 4,662.00 | 2,255.00 | 1,224.10 |
|
Cash Flow from Investing Activities
|
-10,754.00 | 1,498.80 | -4,249.00 | -1,100.00 | 450.20 |
|
Cash from Financing Activities
|
15,502.00 | 56,509.50 | -6,334.00 | -2,953.00 | -371.60 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Axa Equitable Holdings Inc (EQH) | CME Group Inc. Class A (CME) | Intercontinental Exchange (ICE) | Nasdaq (NDAQ) | Cboe Global Markets (CBOE) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-19.68 | 12.96 | 6.77 | 8.28 | 17.32 |
|
ROE (%)
|
-182.66 | 15.47 | 13.56 | 16.25 | 25.14 |
|
ROA (%)
|
-0.25 | 1.26 | 1.51 | 5.87 | 10.48 |
|
EBIT Margin (%)
|
-3.62 | 76.80 | 41.25 | 29.19 | 38.07 |
|
Net Margin (%)
|
-8.72 | 63.08 | 32.27 | 22.60 | 26.73 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Axa Equitable Holdings Inc (EQH) | CME Group Inc. Class A (CME) | Intercontinental Exchange (ICE) | Nasdaq (NDAQ) | Cboe Global Markets (CBOE) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-17.48 | 5.10 | -0.60 | 7.33 | 11.68 |
|
EBIT Growth (%)
|
-131.48 | 3.71 | 6.25 | 15.02 | 45.44 |
|
Net Profit Growth (%)
|
-292.52 | 13.75 | 34.10 | 30.50 | 50.23 |
|
EPS Growth (%)
|
-304.07 | 13.31 | 35.59 | 31.77 | 50.40 |
|
Book Value Growth (%)
|
-174.43 | -4.90 | 5.54 | 3.50 | 20.71 |
Valuation Ratios
| Axa Equitable Holdings Inc (EQH) | CME Group Inc. Class A (CME) | Intercontinental Exchange (ICE) | Nasdaq (NDAQ) | Cboe Global Markets (CBOE) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-9.98 | 24.32 | 28.00 | 31.30 | -- |
|
Price / Book Value
|
-186.16 | 3.42 | 3.20 | 4.58 | -- |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
333.96 | 16.89 | 16.43 | 20.82 | -- |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Axa Equitable Holdings Inc (EQH) | CME Group Inc. Class A (CME) | Intercontinental Exchange (ICE) | Nasdaq (NDAQ) | Cboe Global Markets (CBOE) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
-8.88 | 0.13 | 0.63 | 0.71 | 0.14 |
|
Short term debt to equity ratio
|
-0.26 | 0.00 | 0.04 | 0.02 | 0.12 |
|
Current Ratio
|
10.10 | 1.02 | 1.01 | 0.48 | 1.57 |
|
Quick Ratio
|
10.10 | 1.02 | 0.04 | 0.48 | 1.57 |
|
Interest Coverage
|
-1.70 | 32.98 | 7.82 | 8.07 | 36.63 |
Operating Efficiency Ratios
| Axa Equitable Holdings Inc (EQH) | CME Group Inc. Class A (CME) | Intercontinental Exchange (ICE) | Nasdaq (NDAQ) | Cboe Global Markets (CBOE) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
217.00 | 11.12 | 14.98 | 13.58 | 12.79 |
|
Asset Turnover
|
0.03 | 0.02 | 0.05 | 0.26 | 0.39 |
|
Receivable days
|
574.93 | 33.95 | 91.60 | 43.67 | 37.88 |
|
Inventory Days
|
-- | -- | -- | -- | -- |
|
Payable days
|
672.85 | 30.54 | 80.72 | 23.43 | 53.46 |
|
Cash Conversion Cycle
|
-- | -- | -- | -- | -- |